Transcode Therapeutics, Inc. (16)
Browse by Contract Category
Contracts
-
Description of Securities
(Filed With SEC on March 31, 2022)
-
Specimen Common Stock Certificate
(Filed With SEC on April 8, 2021)
-
Employment Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Robert Michael Dudley
(Filed With SEC on April 8, 2021)
-
Form of Indemnification Agreement between the Registrant and each of its executive officers
(Filed With SEC on March 24, 2021)
-
Exclusive Patent License Agreement by and between TransCode Therapeutics, Inc. and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated as of October 26,...
(Filed With SEC on February 26, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on April 8, 2021)
-
Letter Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Robert Michael Dudley
(Filed With SEC on April 8, 2021)
-
Employment Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Thomas A. Fitzgerald
(Filed With SEC on April 8, 2021)
-
Letter Agreement, dated as of March 24, 2021, by and Between TransCode Therapeutics, Inc. and Thomas A. Fitzgerald
(Filed With SEC on April 8, 2021)
-
Form of Representative Warrant
(Filed With SEC on March 24, 2021)
-
2021 Stock Option and Incentive Plan, and form of award agreements thereunder
(Filed With SEC on March 24, 2021)
-
Senior Executive Cash Incentive Bonus Plan
(Filed With SEC on March 24, 2021)
-
Form of Indemnification Agreement between the Registrant and each of its directors
(Filed With SEC on March 24, 2021)
-
2021 Employee Stock Purchase Plan
(Filed With SEC on March 24, 2021)
-
2020 Stock Option and Grant Plan and form of award agreements thereunder
(Filed With SEC on February 26, 2021)
-
First Amendment to Exclusive Patent License Agreement by and between TransCode Therapeutics, Inc. and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated...
(Filed With SEC on February 26, 2021)
